Paricalcitol is FDA-approved for which of the following condition(s):
Correct Answer: Secondary hyperparathyroidism
Description: Paricalcitol: It is a synthetic calcitriol derivative Reduces serum PTH levels without producing hypercalcemia or altering serum phosphorus Administered orally or intravenously FDA-approved for treating secondary hyperparathyroidism in patients with CKD
Category:
Pharmacology
Get More
Subject Mock Tests
Practice with over 200,000 questions from various medical subjects and improve your knowledge.
Attempt a mock test nowMock Exam
Take an exam with 100 random questions selected from all subjects to test your knowledge.
Coming SoonGet More
Subject Mock Tests
Try practicing mock tests with over 200,000 questions from various medical subjects.
Attempt a mock test now